Moreover, it was shown, for the first time, that CD47 and PD-L1 are co-expressed on single CTCs and that double positive CTCs, as well as CD47high and/or PD-L1high CTCs, also prevail in de novo metastatic BC. Here, CD47 is linked to breast cancer.